Select Publications
Conference Papers
2002, 'Mutant N-ras induces myeloid differentiation in human cord blood CD34+ cells', in BLOOD, AMER SOC HEMATOLOGY, PENNSYLVANIA, PHILADELPHIA, pp. 209B - 209B, presented at 44th Annual Meeting of the American-Society-of-Hematology, PENNSYLVANIA, PHILADELPHIA, 06 December 2002 - 10 December 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179184800888&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Tumor suppressor gene transfer as a therapeutic stratergy for hematopoietic malignancies', in Cancer genetics and tumor supprressor genes conference, Cancer genetics and tumor supprressor genes conference, Frederick, Maryland, pp. 71 - 71, presented at Cancer genetics and tumor supprressor genes conference, Frederick, Maryland, 12 June 1997 - 16 June 1997
,1997, 'Ischemic preconditioning enhances preservation of rat heart during prolonged hypothermic strorage through activation of Katp channels', in Journal of Heart and Lung Transplantation, Elsevier Science Inc, New York, NY, USA, pp. 50, presented at ISHLT: 18th Annual and Scientific meeting of the International Society for Heart and Lung transplant, London, England, 02 April 1997 - 05 April 1997
,1997, 'Tumor suppressor gene transfer as a therapeutic stratergy for hematopoietic malignancies', in Australian Society of Medical research, Australian Society of Medical research, Garvan Institute, Sydney, pp. P-30, presented at Australian Society of Medical research, Garvan Institute, Sydney
,Conference Abstracts
2021, 'CBL0137 promotes CART-cell therapy against MLL-rearranged leukemia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 11 - 12, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2021, 'Using BET inhibitors to potentiate CAR T-cell therapy for neuroblastoma', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 17, pp. 41 - 41, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000074&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'BROMODOMAIN INHIBITOR JQ1 MODULATES IMMUNE SUPPRESSIVE PATHWAYS IN NEUROBLASTOMA AND ENHANCES CARGD2T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700297&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'EPIGENETIC AGENT MODULATES TUMOUR MICROENVIRONMENT AND POTENTIATES CART CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000432441700296&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'FACTORS PROMOTING CD19-NEGATIVE RELAPSES FOLLOWING CAR19T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S8 - S8, http://dx.doi.org/10.1016/j.jcyt.2018.02.009
,2018, 'IMAGING THE DYNAMICS OF RECEPTOR-MODIFIED T CELL EFFECTOR FUNCTION AGAINST LEUKAEMIA AND NEUROBLASTOMA TARGETS', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S103 - S103, http://dx.doi.org/10.1016/j.jcyt.2018.02.301
,2018, 'TUMOUR MICROENVIRONMENT MODULATES CART CELL FATE IN PAEDIATRIC LEUKEMIA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 20, pp. S97 - S97, http://dx.doi.org/10.1016/j.jcyt.2018.02.286
,2017, 'DIFFERING CO-STIMULATORY, LINKER AND SPACER DOMAINS PRODUCE VARIATIONS IN CD4 AND CD8 CELL COMPOSITION AND CYTOTOXIC POTENTIAL IN CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR19) T CELLS GENERATED WITH THE PIGGYBAC TRANSPOSASE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 19, pp. S10 - S10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000399265400010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'PROLONGING CART CELL PERSISTENCE USING CONDITIONING WITH 5-AZACYTIDINE', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S61 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS TO TREAT CANCER', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'USE OF HDACI AND PD-1/PD-LI BLOCKADE TO ENHANCE CYTOLYTIC ACTIVITY OF EX VIVO EXPANDED NK CELLS AGAINST NEUROBLASTOMA', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 18, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'Identifying the Factors Modulating the Efficacy of CAR-T Cell Therapy', in BLOOD, AMER SOC HEMATOLOGY, Vol. 124, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000349242706217&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2014, 'IDENTIFYING THE FACTORS MODULATING THE EFFICACY OF CAR-T CELL THERAPY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 16, pp. S7 - S7, http://dx.doi.org/10.1016/j.jcyt.2014.01.015
,2014, 'TESTING CAR-T CELL ACTIVITY IN HUMAN HEMATOCHIMERIC MOUSE MODEL WITH THE NORMAL RANGE OF ANTIGEN EXPRESSION NOT RESCTRICTED TO THE TUMOUR ONLY', in CYTOTHERAPY, ELSEVIER SCI LTD, Vol. 16, pp. S23 - S23, http://dx.doi.org/10.1016/j.jcyt.2014.01.072
,2012, 'GSK3β Inhibition Promotes T Cell Reconstitution and Preserves Naive T Cell Phenotype in Bone Marrow Reconstituted Mice', in Blood, American Society of Hematology, Vol. 120, pp. 1890 - 1890, http://dx.doi.org/10.1182/blood.v120.21.1890.1890
,2010, 'GSK-3BETA INHIBITION PROMOTES ENGRAFTMENT OF EX VIVO EXPANDED HEMATOPOIETIC STEM CELLS AND MODULATES GENE EXPRESSION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, Vol. 38, pp. S52 - S52, presented at 39th Annual Scientific Meeting of the ISEH - Society-for-Hematology-and-Stem-Cells, AUSTRALIA, Melbourne, 15 September 2010 - 18 September 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281168900106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,